Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP? Cody KoressKevin SwanPhilip Kadowitz Pulmonary Hypertension (JR Klinger, Section Editor) 27 April 2016 Article: 42
Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD? Hermann HallerAnna BertramJan Menne Therapeutic Trials (M Weir, Section Editor) 26 April 2016 Article: 41
Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill M. LafeberW. SpieringD. E. Grobbee Novel Treatments for Hypertension (T Unger, Section Editor) Open access 15 April 2016 Article: 40
Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension Evanthia MergiaJohannes Stegbauer Hypertension and the Kidney (RM Carey, Section Editor) Open access 14 April 2016 Article: 39
Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia Babbette LaMarcaLorena M. AmaralMark W. Cunningham Jr Preeclampsia (V Garovic, Section Editor) 13 April 2016 Article: 38
Hypertension in the Emergency Department Stewart Siu-Wa ChanColin A. GrahamT. H. Rainer Blood Pressure Monitoring and Management (J Cockcroft, Section Editor) 12 April 2016 Article: 37
Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison Martin J WolleyMichael Stowasser Resistant Hypertension (E Pimenta, Section Editor) 12 April 2016 Article: 36
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question) Giorgina Barbara PiccoliGianfranca CabidduTullia Todros Preeclampsia (V Garovic, Section Editor) 12 April 2016 Article: 35
New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension Hafid NarayanDavid J. Webb Hypertension and the Kidney (RM Carey, Section Editor) Open access 12 April 2016 Article: 34